Search - tctmd.com

Displaying 61 - 80 of 122

Sort: Relevancy | Date

Presentation TCT 2017

Amulet: Advanced Tips and Tricks (With Case Examples)

Presenter: Ramon Quesada, Robert J. Sommer, Fabian Nietlispach

October 31, 2017

Presentation TCT 2017

Amulet: Step-by-step Recorded Case

Presenter: Ramon Quesada, Robert J. Sommer, Ruby Satpathy

October 31, 2017

Presentation TCT 2017

Watchman: Advanced Tips and Tricks (With Case Examples)

Presenter: Ramon Quesada, Robert J. Sommer

October 31, 2017

Presentation TCT 2017

Watchman: Step-by-step Recorded Case

Presenter: Ramon Quesada, Robert J. Sommer, Matthew J. Price

October 31, 2017

Presentation TCT 2017

TCT 101: Safety of Double Antiplatelet Therapy as an Alternative to Warfarin Plus Aspirin After Left Atrial Appendage Device Closure - Short-Term Results of WATCHMAN-DAPT Multi-Center Registry

Presenter: Brij Maini, Petr Neuzil, Grzegorz Smolka, MD

October 31, 2017

Presentation TCT 2017

WATCHMAN: Data Synthesis and Ongoing Trials

Presenter: William A. Gray, Vivek Y. Reddy

October 30, 2017

Presentation TCT 2017

Procedural Techniques for Endovascular LAA Occlusion: Watchman Step-by-step (With Discussion)

Presenter: Maurice Buchbinder, Hüseyin Ince, Stephan Kische

October 30, 2017

News Conference News TCT 2017

TCT 2017: High Hopes in Denver for Complex PCI, Shorter DAPT Durations, TAVR Costs, and More

Shelley Wood

October 20, 2017

News Opinion Editor's Corner TCT 2016

我对 2016 年 TCT 的总结：惊喜、假设和赠品

Shelley Wood

November 07, 2016

News Opinion Editor's Corner TCT 2016

My Takeaways From TCT 2016: Surprises, Presuppositions, and the Gift of the Giveaway

Shelley Wood

November 07, 2016

News Opinion Editor's Corner TCT 2016

Con Qué Me Quedo de TCT 2016: Sorpresas, Presuposiciones y Revelaciones

Shelley Wood

November 07, 2016

Presentation TCT 2016

WATCHMAN US POST-APPROVAL STUDY: Multicenter, Prospective, Registry Results With a Left Atrial Appendage Closure Device for Stroke Prevention in Patients With Atrial Fibrillation

Presenter: Martin B. Leon, Louis A. Cannon, David R. Holmes Jr.

November 02, 2016

Presentation TCT 2016

Special Tips and Tricks for LAA Closure Using the Watchman LAA Occluder

Presenter: Krzysztof Bartus, Saibal Kar

November 01, 2016

Presentation TCT 2016

TCT 26: Long-term Event Rates for Left Atrial Appendage Closure With WATCHMAN: PROTECT AF Five-Year and PREVAIL Three-Year Follow-up

Presenter: Zahid Amin, Jacqueline Saw, Vivek Y. Reddy

October 31, 2016

Presentation TCT 2016

Real-world Watchman Outcomes: Insights From the EWOLUTION European Registry

Presenter: Vivek Y. Reddy, Steven J. Yakubov, Martin W. Bergmann

October 30, 2016

Presentation TCT 2016

Use of Watchman in Anticoagulant Contraindicated Patients: Has Safety and Efficacy Been Proven?

Presenter: Vivek Y. Reddy, Steven J. Yakubov, David R. Holmes Jr.

October 30, 2016

Presentation TCT 2016

Meta-analysis and Synthesis of Watchman Trials: Relative Safety and Efficacy vs Warfarin and NOACs in Anticoagulant Indicated Patients (Including Cost-effectiveness)

Presenter: Vivek Y. Reddy, Steven J. Yakubov

October 30, 2016

News Opinion Editor's Corner TCT 2016

TCT 2016: Inspiration and Perspiration Greet Left Main Stenting, Hoop Dreams, Valve Innovation, and Election Fever

Shelley Wood

October 24, 2016

Presentation TCT 2015

Procedural Complications With Watchman: Case Examples

Presenter: Maurice Buchbinder, Zoltan G. Turi, Michael J. Rinaldi

October 13, 2015

Presentation TCT 2015

Complex LAA Closure With Watchman

Presenter: Maurice Buchbinder, Zoltan G. Turi, Matthew J. Price

October 13, 2015

Advertisement

Amulet: Advanced Tips and Tricks (With Case Examples)

Amulet: Step-by-step Recorded Case

Watchman: Advanced Tips and Tricks (With Case Examples)

Watchman: Step-by-step Recorded Case

TCT 101: Safety of Double Antiplatelet Therapy as an Alternative to Warfarin Plus Aspirin After Left Atrial Appendage Device Closure - Short-Term Results of WATCHMAN-DAPT Multi-Center Registry

WATCHMAN: Data Synthesis and Ongoing Trials

Procedural Techniques for Endovascular LAA Occlusion: Watchman Step-by-step (With Discussion)

TCT 2017: High Hopes in Denver for Complex PCI, Shorter DAPT Durations, TAVR Costs, and More

我对 2016 年 TCT 的总结：惊喜、假设和赠品

My Takeaways From TCT 2016: Surprises, Presuppositions, and the Gift of the Giveaway

Con Qué Me Quedo de TCT 2016: Sorpresas, Presuposiciones y Revelaciones

WATCHMAN US POST-APPROVAL STUDY: Multicenter, Prospective, Registry Results With a Left Atrial Appendage Closure Device for Stroke Prevention in Patients With Atrial Fibrillation

Special Tips and Tricks for LAA Closure Using the Watchman LAA Occluder

TCT 26: Long-term Event Rates for Left Atrial Appendage Closure With WATCHMAN: PROTECT AF Five-Year and PREVAIL Three-Year Follow-up

Real-world Watchman Outcomes: Insights From the EWOLUTION European Registry

Use of Watchman in Anticoagulant Contraindicated Patients: Has Safety and Efficacy Been Proven?

Meta-analysis and Synthesis of Watchman Trials: Relative Safety and Efficacy vs Warfarin and NOACs in Anticoagulant Indicated Patients (Including Cost-effectiveness)

TCT 2016: Inspiration and Perspiration Greet Left Main Stenting, Hoop Dreams, Valve Innovation, and Election Fever

Procedural Complications With Watchman: Case Examples

Complex LAA Closure With Watchman

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content